Current Drug Safety,volume 1,issue 2  (01-2006)

Period of time： 2006年2期

Publisher： Bentham Science Publishers

Founded in： 2000

Total resources： 43

E-ISSN： 2212-3911|1|2

ISSN： 1574-8863

Subject：

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Safety,volume 1,issue 2

Menu

Evolving Paradigms in Pharmacovigilance

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-01 , pp. 127-134

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Reducing False Positive Findings in Statistical Analysis of Pharmacogenomic Biomarker Studies Using High-Throughput Technologies

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 135-141

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Psychiatric Side Effects of Interferon Treatment

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 143-150

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

InhaledInsulin: A Novel and Non-Invasive Way for Insulin Administration?

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 151-158

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 159-168

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Role of the New Zealand Intensive Medicines Monitoring Programme in Identification of Previously Unrecognised Signals of Adverse Drug Reactions

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 169-178

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 179-187

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Safety and Efficacy of Parathyroid Hormone (PTH) as a Biological Response Modifier for the Enhancement of Bone Regeneration

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 189-203

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Safety of the Temozolomide in Patients with Malignant Glioma

Current Drug Safety,volume 1,issue 2 , Vol. 1, Iss. 2, 2006-05 , pp. 205-222

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)